Lineage Cell Therapeutics, Inc.

NYSE:LCTX

Biological Products, (No Diagnostic Substances)·CARLSBAD, CA

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/10/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

27 shown

Filed	Period
3/5/26	Q1 FY2026	→
11/6/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/10/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
↓

News (8-K)

53 shown

Filed	Type	Description
11/28/25	Other	Other Events	→
11/24/25	Other	Other Events	→
11/12/25	Other	Other Events	→
8/26/25	Reg FD	Regulation FD Disclosure	→
7/2/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/23/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
11/12/25	424B3	424B3	→
8/15/25	S-8	S-8	→
4/29/25	ARS	ARS	→
11/21/24	424B5	424B5	→
5/14/24	424B5	424B5	→
4/29/24	ARS	ARS	→
↓

Filing History(1002 filings)

TypeDateAccessionPeriodSize

Mar 6, 2026

0001193125-26-0971854

Mar 5, 2026

5.3 KB

Mar 6, 2026

0001193125-26-0971844

Mar 5, 2026

5.3 KB

Mar 6, 2026

0001193125-26-0971814

Mar 5, 2026

5.3 KB

10-K

Mar 5, 2026

0001193125-26-09399210-K

Dec 31, 2025

18.7 MB

8-K

Mar 5, 2026

0001193125-26-0939488-K

Mar 5, 2026

700.9 KB

Feb 13, 2026

0001193125-26-0520214

Feb 11, 2026

8.9 KB

Feb 13, 2026

0001193125-26-0520204

Feb 11, 2026

8.9 KB

Dec 19, 2025

0001193125-25-3272804

Dec 19, 2025

6.8 KB

Dec 19, 2025

0001193125-25-3272794

Dec 19, 2025

6.8 KB

8-K

Nov 28, 2025

0001193125-25-3025528-K

Nov 28, 2025

140.6 KB

8-K

Nov 24, 2025

0001193125-25-2919798-K

Nov 20, 2025

140.2 KB

SCHEDULE 13D/A

Nov 14, 2025

0000919574-25-007051

—

23.0 KB

8-K

Nov 12, 2025

0001193125-25-2762498-K

Nov 12, 2025

138.0 KB

424B3

Nov 12, 2025

0001193125-25-276229424B3

—

61.1 KB

10-Q

Nov 6, 2025

0001193125-25-26959910-Q

Sep 30, 2025

10.5 MB

8-K

Nov 6, 2025

0001193125-25-2695348-K

Nov 6, 2025

732.6 KB

SCHEDULE 13G

Sep 26, 2025

0002042077-25-000004

—

6.1 KB

144

Sep 24, 2025

0001950047-25-007493

—

5.3 KB

144

Sep 10, 2025

0001950047-25-006959

—

4.6 KB

8-K

Aug 26, 2025

0000950170-25-1113198-K

Aug 26, 2025

241.6 KB

S-8

Aug 15, 2025

0000950170-25-109396S-8

—

301.0 KB

10-Q

Aug 12, 2025

0000950170-25-10733310-Q

Jun 30, 2025

11.0 MB

8-K

Aug 12, 2025

0000950170-25-1073148-K

Aug 12, 2025

706.3 KB

SCHEDULE 13G/A

Jul 17, 2025

0002052113-25-003083

—

10.5 KB

Jul 3, 2025

0000919574-25-003973

Jul 1, 2025

13.1 KB

25 filings shown

Filed	Form	Description
6/11/25	DEFA14A	DEFA14A	→
4/29/25	DEFA14A	DEFA14A	→
4/29/25	DEF 14A	DEF 14A	→
12/9/24	DEF 14A	DEF 14A	→
11/29/24	PRE 14A	PRE 14A	→
4/29/24	DEFA14A	DEFA14A	→
↓

Lineage Cell Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1002 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/6/26	4	4	→
3/6/26	4	4	→
3/6/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
12/19/25	4	4	→
↓

Filed	Form	Description
11/14/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
9/26/25	SCHEDULE 13G	SCHEDULE 13G	→
9/24/25	144	144	→
9/10/25	144	144	→
7/17/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/24/25	SCHEDULE 13G	SCHEDULE 13G	→
↓